CD8A and relapsing-remitting multiple sclerosis: In accordance with these findings, we detected higher fractions of CD8+ memory and effector Tc (KLRG1+ (activated) CD8+ TTM, and (activated) CD8+ TTE) in RRMS patients compared to HC.